Rivastigmine
NDC 0781-7313, rivastigmine, patch, extended release, from Sandoz Inc.
- Product NDC
- 0781-7313
- Status
- Listed
- Labeler
- Sandoz Inc
- Dosage form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA022083
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0781-7313 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIVASTIGMINE13.3 mg/24h
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0781-7313-31 | 00781731331 | 30 PATCH in 1 CARTON (0781-7313-31) / 24 h in 1 PATCH (0781-7313-58) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/92a58ebb-748d-49f4-bf11-ecbcf5424152NADAC price for package 00781731331
GET /v1/drugs/nadac/00781731331
Use it
Look up 0781-7313 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0781-7313 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0781-7313. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.